Please fill out the form to view this content.
Dr Adrien Soula of the Cell and Gene Therapy Catapult will present brand new data from a study, completed in June 2021, that showed a significant increase in yield and quality of an AAV resulting from a timed osmolality shift. Additionally, his data will show how the shift had a profound effect on the relative extracellular vs intracellular vector yield with exciting implications.